National Health Investors (NYSE:NHI - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.590-4.660 for the period, compared to the consensus earnings per share estimate of 4.690. The company issued revenue guidance of -.
National Health Investors Stock Performance
National Health Investors stock traded up $0.28 during mid-day trading on Friday, hitting $71.53. 476,557 shares of the company's stock traded hands, compared to its average volume of 203,196. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The stock has a market cap of $3.27 billion, a price-to-earnings ratio of 24.58, a P/E/G ratio of 4.42 and a beta of 1.06. The firm has a 50 day simple moving average of $68.72 and a two-hundred day simple moving average of $75.01. National Health Investors has a fifty-two week low of $56.70 and a fifty-two week high of $86.13.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.03. The firm had revenue of $85.75 million for the quarter, compared to analysts' expectations of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. On average, research analysts expect that National Health Investors will post 4.41 EPS for the current fiscal year.
National Health Investors Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.03%. The ex-dividend date of this dividend is Monday, March 31st. National Health Investors's payout ratio is currently 115.38%.
Analysts Set New Price Targets
Separately, Truist Financial decreased their target price on National Health Investors from $78.00 to $72.00 and set a "hold" rating on the stock in a research report on Monday, December 23rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $76.60.
Read Our Latest Stock Analysis on NHI
About National Health Investors
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
